AVE Science & Technology Co Ltd (688067) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.02 Million ≈ $2.20 Million USD) by net assets (CN¥518.37 Million ≈ $75.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688067 company net worth for the company's overall valuation and market capitalisation.
AVE Science & Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how AVE Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
AVE Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AVE Science & Technology Co Ltd ranked by their cash flow conversion efficiency. Explore AVE Science & Technology Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asia Cement
KO:002030
|
0.032x |
|
Hyundai Cement
KO:006390
|
0.059x |
|
Asure Software Inc
NASDAQ:ASUR
|
0.023x |
|
Nu Skin Enterprises Inc
NYSE:NUS
|
0.020x |
|
Illumination Acquisition Corp I Class A Ordinary Shares
NASDAQ:ILLU
|
N/A |
|
Astral Resources NL
AU:AAR
|
-0.011x |
|
Warriedar Resources Ltd
AU:WA8
|
0.016x |
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
-0.020x |
Annual Cash Flow Conversion Efficiency for AVE Science & Technology Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of AVE Science & Technology Co Ltd from 2012 to 2024. View 688067 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥495.85 Million ≈ $72.56 Million |
CN¥22.41 Million ≈ $3.28 Million |
0.045x | -2.60% |
| 2023-12-31 | CN¥489.84 Million ≈ $71.68 Million |
CN¥22.73 Million ≈ $3.33 Million |
0.046x | -25.87% |
| 2022-12-31 | CN¥475.12 Million ≈ $69.52 Million |
CN¥29.74 Million ≈ $4.35 Million |
0.063x | -36.65% |
| 2021-12-31 | CN¥477.58 Million ≈ $69.88 Million |
CN¥47.19 Million ≈ $6.90 Million |
0.099x | -50.17% |
| 2020-12-31 | CN¥236.72 Million ≈ $34.64 Million |
CN¥46.93 Million ≈ $6.87 Million |
0.198x | -19.38% |
| 2019-12-31 | CN¥252.51 Million ≈ $36.95 Million |
CN¥62.10 Million ≈ $9.09 Million |
0.246x | +32.38% |
| 2018-12-31 | CN¥217.27 Million ≈ $31.79 Million |
CN¥40.36 Million ≈ $5.91 Million |
0.186x | +42.49% |
| 2017-12-31 | CN¥189.95 Million ≈ $27.80 Million |
CN¥24.76 Million ≈ $3.62 Million |
0.130x | -25.67% |
| 2016-12-31 | CN¥177.84 Million ≈ $26.02 Million |
CN¥31.19 Million ≈ $4.56 Million |
0.175x | +21.23% |
| 2015-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥21.35 Million ≈ $3.12 Million |
0.145x | -14.61% |
| 2014-12-31 | CN¥138.28 Million ≈ $20.24 Million |
CN¥23.43 Million ≈ $3.43 Million |
0.169x | +38.06% |
| 2013-12-31 | CN¥121.15 Million ≈ $17.73 Million |
CN¥14.87 Million ≈ $2.18 Million |
0.123x | -6.50% |
| 2012-12-31 | CN¥103.11 Million ≈ $15.09 Million |
CN¥13.53 Million ≈ $1.98 Million |
0.131x | -- |
About AVE Science & Technology Co Ltd
AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more